Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Energetics and Function in Older Humans
Authors not listed
Baylor College of Medicine · 2014
Abstract
The investigators have previously reported that older patients with HIV are deficient in glutathione (GSH) due to decreased availability of cysteine and glycine, and that oral supplementation with cysteine (as n-acetylcysteine) and glycine for 2-weeks corrects their own levels, and improves concentrations of red-cell GSH. The investigators also found that when GSH deficient, subjects had impaired mitochondrial energetics and this improved with an increase in intracellular GSH concentrations. The current proposal will investigate if cysteine and glycine supplementation for a duration of 24 weeks will result in changes in : (a) GSH levels; (b) body composition/anthropometry; (c) strength and function; (d) quality of life; (e) mitochondrial energetics; (f) biochemistry (including dyslipidemia and oxidative stress); (g) protein and glucose metabolism; (h) cognition and memory. 3 months after completing supplementation, measurement of GSH concentrations, strength, function, mitochondrial energetics and neurocognitive tests will be done to determine the effects of washout.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-16 MST
Cite this
APA
Anonymous. (2014). Energetics and Function in Older Humans. <em>Baylor College of Medicine</em>. https://clinicaltrials.gov/study/NCT02348762
Vancouver
Anonymous. Energetics and Function in Older Humans. Baylor College of Medicine. 2014.
BibTeX
@misc{anon2014Energe,
title = {Energetics and Function in Older Humans},
author = {Anonymous},
journal = {Baylor College of Medicine},
year = {2014},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
bioRxiv (Cold Spring Harbor Laboratory) 2018
Preprint · OA
Alpha-synuclein-induced mitochondrial dysfunction is mediated via a sirtuin 3-dependent pathway
International Journal of Molecular Sciences 2024
Open access · CC-BY
Targeting Mitochondrial Dysfunction and Reactive Oxygen Species for Neurodegenerative Disease Treatment
Molecular Neurodegeneration 2020
Open access · CC-BY
Alpha-synuclein-induced mitochondrial dysfunction is mediated via a sirtuin 3-dependent pathway
Expert review of clinical pharmacology 2026
Citation only
Osteoarthritis and dementia: contrasting disorders driven by mutual pathways of autophagy, mTOR, GLP-1, AMPK, Wnt, and WISP1.
Baylor College of Medicine 2022
Open access · US-GOV
Glutathione, Brain Metabolism and Inflammation in Alzheimer's Disease
HAL 2018
Preprint · OA